GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Cannabinoid Technologies Holdings PLC (FRA:0CB) » Definitions » Revenue per Share

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Revenue per Share : €0.00 (TTM As of Oct. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Cannabinoid Technologies Holdings Revenue per Share?

Oxford Cannabinoid Technologies Holdings's revenue per share for the six months ended in Oct. 2023 was €0.00. Oxford Cannabinoid Technologies Holdings's revenue per share for the trailing twelve months (TTM) ended in Oct. 2023 was €0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Oxford Cannabinoid Technologies Holdings's Revenue per Share or its related term are showing as below:

FRA:0CB's 3-Year Revenue Growth Rate is not ranked *
in the Biotechnology industry.
Industry Median: 4
* Ranked among companies with meaningful 3-Year Revenue Growth Rate only.

Oxford Cannabinoid Technologies Holdings Revenue per Share Historical Data

The historical data trend for Oxford Cannabinoid Technologies Holdings's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Cannabinoid Technologies Holdings Revenue per Share Chart

Oxford Cannabinoid Technologies Holdings Annual Data
Trend May18 May19 May20 May21 Apr23
Revenue per Share
- - - - -

Oxford Cannabinoid Technologies Holdings Semi-Annual Data
May19 Nov19 May20 Nov20 May21 Nov21 Oct22 Apr23 Oct23
Revenue per Share Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Oxford Cannabinoid Technologies Holdings's Revenue per Share

For the Biotechnology subindustry, Oxford Cannabinoid Technologies Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford Cannabinoid Technologies Holdings's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford Cannabinoid Technologies Holdings's PS Ratio distribution charts can be found below:

* The bar in red indicates where Oxford Cannabinoid Technologies Holdings's PS Ratio falls into.



Oxford Cannabinoid Technologies Holdings Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Oxford Cannabinoid Technologies Holdings's Revenue Per Share for the fiscal year that ended in Apr. 2023 is calculated as

Revenue Per Share (A: Apr. 2023 )=Revenue (A: Apr. 2023 )/Shares Outstanding (Diluted Average) (A: Apr. 2023 )
=0/960.416
=0.00

Oxford Cannabinoid Technologies Holdings's Revenue Per Share for the quarter that ended in Oct. 2023 is calculated as

Revenue Per Share (Q: Oct. 2023 )=Revenue (Q: Oct. 2023 )/Shares Outstanding (Diluted Average) (Q: Oct. 2023 )
=0/960.416
=0.00

Revenue per Share for the trailing twelve months (TTM) ended in Oct. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Cannabinoid Technologies Holdings  (FRA:0CB) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Oxford Cannabinoid Technologies Holdings Revenue per Share Related Terms

Thank you for viewing the detailed overview of Oxford Cannabinoid Technologies Holdings's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Cannabinoid Technologies Holdings (FRA:0CB) Business Description

Traded in Other Exchanges
Address
267 Banbury Road, Prama House, Oxford, GBR, OX2 7HT
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Oxford Cannabinoid Technologies Holdings (FRA:0CB) Headlines

No Headlines